Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innovative EyewearLUCY -12.03%61 PB Ratio is 0.63 as of Jul. 15, 2026, which is 33% below its 10-year median of 0.94. GuruFocus rates LUCY with a GF Score™ of 61/100 and a GF Value™ of $1.80 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Innovative Eyewear ranks better than 87.8% on this metric.
The historical rank and industry rank for Innovative Eyewear's PB Ratio or its related term are showing as below:
LUCY'
s PB Ratio Range Over the Past 10 Years
Min: 0.57 Med: 0.94 Max: 6.75
Current: 0.63
During the past 7 years, Innovative Eyewear's highest PB Ratio was 6.75. The lowest was 0.57. And the median was 0.94.
LUCY's PB Ratio is ranked better than 87.8% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs LUCY: 0.63
During the past 12 months, Innovative Eyewear's average Book Value Per Share Growth Rate was -56.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -46.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Innovative Eyewear was 90.20% per year. The lowest was -46.90% per year. And the median was 21.65% per year.
Back to Basics: PB Ratio
Innovative Eyewear (NAS:LUCY) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Innovative Eyewear PB Ratio Related Terms
Innovative Eyewear PB Ratio Historical Data
* Premium members only.
The historical data trend for Innovative Eyewear's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's PB Ratio distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Innovative Eyewear (LUCY) has a PB Ratio of 0.63 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Innovative Eyewear and its competitors. This is 33% below median its historical median of 0.94. Over the past decade, Innovative Eyewear's PB Ratio has ranged from 0.57 to 6.75. According to the industry distribution chart, Innovative Eyewear ranks #96 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 12.2%.
Is Innovative Eyewear's PB Ratio too high?
Innovative Eyewear's current PB Ratio of 0.63 is 33% below median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 6.75. The Medical Devices & Instruments industry median PB Ratio is 2.05. Innovative Eyewear's value of 0.63 is 69.3% below this industry median. Based on the distribution chart, Innovative Eyewear ranks #96 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Innovative Eyewear has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's PB Ratio compare to NXGL and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #96 out of 787 companies for PB Ratio. This places Innovative Eyewear in the top 12% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Innovative Eyewear's value of 0.63 is 69.3% below this benchmark. Historically, Innovative Eyewear's own PB Ratio has ranged from 0.57 to 6.75 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 2.05, Innovative Eyewear has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovative Eyewear's current PB Ratio of 0.63 is 69.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Innovative Eyewear and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current PB Ratio is 0.63, which is 33% below median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.80, compared to a current price of $0.84 — trading 53.3% below its estimated fair value. The current PB Ratio is 0.63, which is 33% below median its 10-year median of 0.94 and 69.3% below the Medical Devices & Instruments industry median of 2.05. Innovative Eyewear's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current PB Ratio is 0.63 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.84 is trading 53.3% below its estimated GF Value™ of $1.80.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
PB Ratio: 0.63 (33% below median its 10-year median of 0.94)
GF Value™: $1.80 vs. price of $0.84 (53.3% below fair value)
Industry Position: 69.3% below the Medical Devices & Instruments median (#96 of 787)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
61GF Score
Get the complete analysis for LUCY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
